Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming Group N.V (PHAR) Total Debt: 2019-2021

Historic Total Debt for Pharming Group N.V (PHAR) over the last 3 years, with Dec 2021 value amounting to $165,000.

  • Pharming Group N.V's Total Debt fell 62.95% to $143,000 in Q3 2022 from the same period last year, while for Sep 2022 it was $143,000, marking a year-over-year decrease of 99.45%. This contributed to the annual value of $165,000 for FY2021, which is 99.35% down from last year.
  • Per Pharming Group N.V's latest filing, its Total Debt stood at $165,000 for FY2021, which was down 99.35% from $25.2 million recorded in FY2020.
  • Pharming Group N.V's Total Debt's 5-year high stood at $39.4 million during FY2019, with a 5-year trough of $165,000 in FY2021.
  • Over the past 3 years, Pharming Group N.V's median Total Debt value was $25.2 million (recorded in 2020), while the average stood at $21.6 million.
  • Data for Pharming Group N.V's Total Debt shows a maximum YoY slumped of 99.35% (in 2021) over the last 5 years.
  • Pharming Group N.V's Total Debt (Yearly) stood at $39.4 million in 2019, then plummeted by 35.98% to $25.2 million in 2020, then slumped by 99.35% to $165,000 in 2021.